ProductUpdated on 24 October 2025
Accelerate your clinical algorithm/prediction model to market with Evidencio’s CE-Certification Roadmap
Internist, chief medical officer @Evidencio at Evidencio
Groningen, Netherlands
About
As a developer or IP-owner of a clinical algorithm, you partner with Evidencio for the full regulatory journey — from conception to CE-marked medical-device software. We act as your Legal Manufacturer, leveraging our ISO 13485-compliant quality system and ISO 27001/NEN 7510-compliant cloud-enabled infrastructure to streamline your pathway.
With us you receive:
-
A pre-assessment that clarifies classification, intended use, risk class and scope — starting at a fixed price.
-
Technical-file development, leveraging a proven QMS and infrastructure to reduce cost and risk.
-
A full CE-certification process including Notified Body engagement, clinical evidence generation and conformity assessment — all managed for you.
-
After CE-certification, you can market and distribute your algorithm yourself, jointly, or use Evidencio’s international network for deployment.
Why choose Evidencio?
-
Significantly reduced cost and lead-time thanks to reuse of infrastructure and QMS.
-
Full regulatory compliance with ISO 13485, ISO 27001 and NEN7510 — so security, data protection and device regulation are already built-in.
-
A single partner handling both the technical deployment and regulatory certification, enabling you to focus on your algorithm and clinical value.
Let Evidencio carry the regulatory burden — so your algorithm becomes a CE-certified, market-ready medical device tool.
Organisation
Similar opportunities
Product
Regulatory Strategy for Software as a Medical Device (SaMD)
- Product
- Looking for project partners
David Howarth
Managing Director | Principal Consultant at iDE8
inverness, United Kingdom
Product
Quality System Support for Medical Devices
- Product
- Looking for project partners
David Howarth
Managing Director | Principal Consultant at iDE8
inverness, United Kingdom
Product
£1.5M Round to Scale AI-Powered Diagnostic Platform
- Looking for an investor
Roman Belkin
CBDO at HQ Science Ltd
London, United Kingdom